Skip to content
NASDAQ · PHARMACEUTICAL PREPARATIONS · SMALL CAP

Exicure, Inc. XCUR

10 fiscal years on record · USD · FY2025 reported · SEC filings only
$0
▼ 100.0% YoY
$-4.9M
$-8.6M

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Growth

USD 0.00
Revenue, FY2025 · full 10-year series below
Revenue $M Net income $M
FY2025 · Revenue 0.0 · Net income -4.9
15.0M30.0M-25.0M-50.0M
2016201920222025
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

·
Operating margin Net margin
FY2024 · Operating -2446.4% · Net ·
5000%10000%-1000%-2000%
201620202025
ROE
FY2025 · ROE -92.5%
-200%-400%-600%
201620202025
Three returns, three denominators.

Each USD of equity lost 92 cents this year.

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -8.6
-15M-30M
201620202025

Total assetsUSD 14.0M
EquityUSD 3.9M
CashUSD 3.7M
Current ratio1.19×

Equity funds 28% of total assets.

The 10-year record

10 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
XCUR, 10-year financial record
Metric 2025202420232022202120202019201820172016
Revenue $B0.00.00.00.0−0.00.00.00.00.00.0
Operating income $B−0.0−0.0−0.0−0.0−0.1−0.0−0.0−0.0−0.0−0.0
EBITDA $B−0.0−0.0−0.0−0.0−0.1−0.0−0.0−0.0−0.0−0.0
Income tax $B−0.00.00.00.00.00.00.00.00.00.0
Net income $B−0.0−0.0−0.0−0.0−0.1−0.0−0.0−0.0−0.0−0.0
Free cash flow $B−0.0−0.0−0.0−0.0−0.0−0.00.0−0.0−0.0−0.0
EPS, diluted $−0.79−4.75−10.55−0.56−21.70−0.28−0.46−0.54−1.09−149.37
Dividend / sh $◌◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend——————————
ROE %−92.5−197.9−188.4−19.7−176.3−34.7−51.7−109.5−98.2−692.0
Shares out B0.010.010.010.000.110.090.090.040.040.00

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 40 reconciliationsAUDITED

Reconciled in 10 of the 10 fiscal years we could check. 18 checks were skipped: the balance sheet is not tagged before 2016. Nine checks were skipped: EPS is not tagged before 2016.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityPharmaceutical Preparations
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2016

Share this section

Download image